Feola S, Russo S, Martins B, Lopes A, Vandermeulen G, Flühler V, et al. Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine. Front Immunol. 2022;13:826164 pubmed publisher

Rodrigues da Silva R, Correa Moreira D, Soares I, De Luca P, Totino P, Morgado F, et al. Immunogenicity of synthetic peptide constructs based on PvMSP9E795-A808, a linear B-cell epitope of the P. vivax Merozoite Surface Protein-9. Vaccine. 2019;37:306-313 pubmed publisher

Petkov S, Starodubova E, Latanova A, Kilpelainen A, Latyshev O, Svirskis S, et al. DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response. PLoS ONE. 2018;13:e0197902 pubmed publisher

Altenburg A, Magnusson S, Bosman F, Stertman L, de Vries R, Rimmelzwaan G. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice. Clin Exp Immunol. 2017;190:19-28 pubmed publisher

Torcellan T, Hampton H, Bailey J, Tomura M, Brink R, Chtanova T. In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors. Proc Natl Acad Sci U S A. 2017;114:5677-5682 pubmed publisher